Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CRSP

CRISPR Therapeutics AG

Sep 12 • 09:32AM ET

45.49

Dollar change +0.05
Percentage change 0.11	%

Healthcare • Biotechnology • Switzerland • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: ARKK XBI ARKG VXF IBB SCHA VHT XT SCHM LABU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.23	Insider Own	4.35%	Shs Outstand	85.17M	Perf Week	0.53%
Market Cap	3.87B	Forward P/E	-	EPS next Y	-4.86	Insider Trans	-1.72%	Shs Float	81.46M	Perf Month	-5.66%
Income	-265.80M	PEG	-	EPS next Q	-1.42	Inst Own	63.28%	Short Float	21.41%	Perf Quarter	-29.83%
Sales	202.23M	P/S	19.16	EPS this Y	-188.67%	Inst Trans	-0.04%	Short Ratio	13.90	Perf Half Y	-39.17%
Book/sh	23.29	P/B	1.95	EPS next Y	13.24%	ROA	-11.72%	Short Interest	17.44M	Perf Year	-10.93%
Cash/sh	23.50	P/C	1.94	EPS next 5Y	-	ROE	-14.00%	52W Range	37.55 - 91.10	Perf YTD	-27.33%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.83%	ROI	-12.11%	52W High	-50.07%	Beta	1.68
Dividend TTM	-	Quick Ratio	15.73	Sales past 5Y	33402.13%	Gross Margin	31.46%	52W Low	21.15%	ATR (14)	1.90
Dividend Ex-Date	-	Current Ratio	15.73	EPS Y/Y TTM	39.60%	Oper. Margin	-163.80%	RSI (14)	39.26	Volatility	3.65% 3.84%
Employees	407	Debt/Eq	0.12	Sales Y/Y TTM	18.89%	Profit Margin	-131.44%	Recom	2.20	Target Price	80.79
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	-51.44%	Payout	-	Rel Volume	0.25	Prev Close	45.44
Sales Surprise	-95.71%	EPS Surprise	-4.38%	Sales Q/Q	-99.26%	Earnings	Aug 05 AMC	Avg Volume	1.25M	Price	45.49
SMA20	-3.69%	SMA50	-11.62%	SMA200	-25.90%	Trades		Volume	17,162	Change	0.11%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Reiterated	Needham	Buy	$88 → $84
Aug-02-24	Initiated	Rodman & Renshaw	Buy	$90
Jun-28-24	Resumed	Guggenheim	Neutral
Feb-15-24	Initiated	Wolfe Research	Peer Perform
Dec-11-23	Downgrade	TD Cowen	Market Perform → Underperform	$30
Oct-17-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-27-23	Initiated	Mizuho	Buy	$82
Aug-17-23	Upgrade	Citigroup	Neutral → Buy
May-30-23	Initiated	William Blair	Outperform	$75
Apr-13-23	Initiated	Cantor Fitzgerald	Overweight	$72
Mar-21-23	Initiated	Bernstein	Mkt Perform	$44
Mar-17-23	Initiated	Bryan Garnier	Buy	$70
Mar-07-23	Initiated	Robert W. Baird	Neutral	$46
Oct-11-22	Initiated	Morgan Stanley	Underweight	$37
Aug-09-22	Downgrade	Barclays	Overweight → Equal Weight	$99 → $88
Jun-23-22	Downgrade	Evercore ISI	Outperform → In-line	$66 → $60
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$98
Apr-28-22	Initiated	Credit Suisse	Neutral	$78
Dec-07-21	Initiated	Cowen	Market Perform
Oct-19-21	Initiated	SVB Leerink	Outperform	$126

Show Previous Ratings

Today 08:45AM	1 Biotech Stock Down 62% to Buy and Hold (Motley Fool)
04:15AM	3 No-Brainer Biotech Stocks to Buy With $200 Right Now (Motley Fool)
Sep-10-24 05:50PM	CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why (Zacks)
Sep-08-24 04:51PM	CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
08:45AM	Loading…
Sep-05-24 08:45AM	Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal? (Motley Fool)
Sep-04-24 11:30AM	Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report? (Zacks)
Sep-02-24 06:15PM	3 Monster Biotech Stocks to Buy Before 2025 (Motley Fool)
Aug-30-24 08:19PM	Vertex Pharmaceutical Inc. (VRTX): Jim Cramer's Go-To Stock For Success (Insider Monkey)
Aug-26-24 07:30AM	Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 (Motley Fool)
Aug-19-24 11:43AM	CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock? (Zacks)
Aug-11-24 07:28AM	Got the Market Sell-Off Blues? Do These 3 Things Right Now (Motley Fool)
Aug-09-24 10:19AM	3 Gene Editing Stocks with Potential to Transform Medicine (InvestorPlace)
Aug-08-24 04:56PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
06:00AM	7 Biotech Stocks to Buy for Their Game-Changing Potential (InvestorPlace)
09:00AM	Loading…
Aug-07-24 09:00AM	The 3 Best Gene Editing Stocks to Buy in August 2024 (InvestorPlace)
Aug-06-24 10:37AM	CRISPR Therapeutics (CRSP) Q2 Loss Wider Than Expected (Zacks)
Aug-05-24 05:25PM	CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:01PM	CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-04-24 06:22AM	Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker (Motley Fool)
Aug-01-24 12:21PM	CRISPR Therapeutics AG (CRSP): Ark Invest is Bullish on This Stock Right Now (Insider Monkey)
Jul-31-24 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-30-24 09:00AM	Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know (Zacks)
Jul-29-24 04:00PM	The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 (InvestorPlace)
10:00AM	Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-26-24 05:50PM	CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Jul-24-24 08:53AM	CRISPR Therapeutics Nears 52-Week Low. Time to Buy? (TipRanks)
Jul-23-24 06:00PM	CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
09:48AM	Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings? (Zacks)
Jul-22-24 04:45PM	3 Gene Editing Stocks Shaping the Future of Medicine (InvestorPlace)
06:00AM	Loading…
Jul-20-24 06:00AM	3 Monster Stocks in the Making to Buy Right Now (Motley Fool)
Jul-17-24 01:30PM	3 Gene Editing Stocks That Could Grow Your Wealth (InvestorPlace)
11:30AM	3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition (InvestorPlace)
06:08AM	CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last? (Zacks)
Jul-16-24 01:37PM	Dow, S&P 500 rally on strong retail data, gold reaches record high: Yahoo Finance (Yahoo Finance Video) +9.21%
04:15AM	Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? (Motley Fool)
Jul-11-24 08:45AM	1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Jul-10-24 06:00PM	Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market Today (Zacks)
Jul-09-24 07:59AM	3 Profitable CRISPR Stocks Earning Analysts' Praise (InvestorPlace)
07:30AM	7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030 (InvestorPlace)
07:00AM	The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-08-24 09:00AM	The 3 Best Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
06:00AM	3 Pharma Stocks Already Ushering in the Next Biotech Boom (InvestorPlace)
Jul-03-24 03:11PM	3 Top-Rated Gene Editing Stocks Actually Making Money (InvestorPlace)
Jul-01-24 08:40PM	Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years? (Insider Monkey)
02:31PM	10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood (Insider Monkey)
Jun-27-24 10:02PM	You've Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. (InvestorPlace)
06:39PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
03:38PM	Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich (InvestorPlace)
02:21PM	You've Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. (InvestorPlace)
08:00AM	Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued." (Motley Fool)
06:40AM	3 Biotech Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
Jun-26-24 09:33PM	Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich (InvestorPlace)
06:00PM	CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jun-25-24 08:00AM	3 Gene Editing Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
Jun-24-24 10:54AM	The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom (InvestorPlace)
09:00AM	Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now? (Zacks)
Jun-20-24 06:00PM	CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.64%
Jun-19-24 02:46PM	CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon? (TipRanks)
Jun-13-24 05:50PM	CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jun-12-24 06:30PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
01:44PM	7 FIRE Stocks to Put You on the Path to Financial Freedom (InvestorPlace)
Jun-11-24 09:00AM	CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-09-24 06:20AM	Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought (Motley Fool)
Jun-07-24 11:30AM	Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? (Zacks)
11:25AM	Cathie Wood Invests In 2 Biotechnology Stocks Are They Worth Buying? (Benzinga)
Jun-04-24 06:45AM	Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? (Motley Fool)
May-29-24 04:30PM	7 Stocks You Haven't Heard of (That EVERYONE Should Own) (InvestorPlace)
09:00AM	CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:00AM	CRISPR Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-27-24 12:32PM	7 Biotech Stocks to Put on Your Breakthrough Radar (InvestorPlace)
May-26-24 09:15AM	3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow (Motley Fool)
May-23-24 08:00AM	CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments (GlobeNewswire)
07:10AM	The 2030 Millionaire's Club: 3 Biotech Stocks to Buy Now (InvestorPlace)
May-22-24 09:22AM	7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition (InvestorPlace)
09:10AM	Is CRISPR Therapeutics a Millionaire Maker? (Motley Fool)
06:40AM	Bull Market Buys: 2 Growth Stocks to Own for the Long Run (Motley Fool)
May-17-24 03:46PM	BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions? (TipRanks)
09:30AM	Is CRISPR Therapeutics Stock a Buy? (Motley Fool)
06:15AM	Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 (InvestorPlace)
May-16-24 06:40AM	7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 (InvestorPlace)
May-15-24 11:11AM	Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. (Motley Fool)
May-14-24 10:07AM	2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential (Motley Fool)
May-13-24 02:18PM	15 Best ARK Stocks To Buy Now (Insider Monkey) +8.76%
09:00AM	Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know (Zacks)
06:04AM	The 3 Best Cathie Wood Stocks to Buy in May 2024 (InvestorPlace)
May-11-24 10:00AM	The 3 Most Undervalued Biotech Stocks to Buy in May 2024 (InvestorPlace)
May-10-24 12:42PM	CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast (GuruFocus.com)
10:06AM	Oppenheimer Adjusts CRISPR Therapeutics Price Target to $95 From $102, Maintains Outperform Rating (MT Newswires)
06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-09-24 11:12AM	Barclays Adjusts Price Target on CRISPR Therapeutics to $67 From $80, Maintains Equal-Weight Rating (MT Newswires)
11:11AM	Needham Adjusts Price Target on CRISPR Therapeutics to $88 From $90, Keeps Buy Rating (MT Newswires)
10:58AM	CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss (Zacks)
10:12AM	Baird Adjusts Price Target on CRISPR Therapeutics to $52 From $46, Keeps Neutral Rating (MT Newswires)
08:30AM	CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
06:49AM	Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine (InvestorPlace)
May-08-24 10:58PM	CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:40PM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
05:10PM	CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:00PM	CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results (GlobeNewswire)

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bruno Julianne	Chief Operating Officer	Jun 21 '24	Sale	56.09	3,366	188,799	6,745	Jun 24 05:35 PM
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Option Exercise	19.12	19,582	374,408	227,704	Apr 17 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Sale	59.91	19,582	1,173,232	208,122	Apr 17 05:45 PM
Prasad Raju	Chief Financial Officer	Mar 15 '24	Sale	72.69	3,524	256,160	6,476	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Option Exercise	19.12	20,000	382,400	228,122	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Sale	72.48	20,000	1,449,628	208,122	Mar 18 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Mar 11 '24	Sale	78.26	2,801	219,206	60,070	Mar 12 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Mar 12 '24	Sale	74.44	1,146	85,308	61,174	Mar 12 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 11 '24	Sale	78.26	9,802	767,105	203,705	Mar 12 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 12 '24	Sale	74.44	4,583	341,159	208,122	Mar 12 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Feb 20 '24	Sale	79.67	1,913	152,409	57,371	Feb 21 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 20 '24	Sale	79.67	6,370	507,498	194,257	Feb 21 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 15 '24	Option Exercise	19.12	20,000	382,400	207,377	Feb 16 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 15 '24	Sale	80.36	20,000	1,607,177	187,377	Feb 16 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 29 '24	Option Exercise	19.12	50,000	956,000	237,377	Jan 31 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 29 '24	Sale	60.51	50,000	3,025,573	187,377	Jan 31 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 16 '24	Option Exercise	19.12	20,000	382,400	207,377	Jan 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 16 '24	Sale	62.50	20,000	1,250,058	187,377	Jan 18 05:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRSP

CRISPR Therapeutics AG

Upgrade your FINVIZ experience